Teladoc Health, Inc.
TDOC
$5.35
-$0.17-3.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 79.99% | 77.23% | 79.38% | -334.44% | -354.35% |
| Total Depreciation and Amortization | -16.41% | -24.29% | -26.96% | -18.16% | -6.00% |
| Total Amortization of Deferred Charges | 25.99% | 35.08% | 45.59% | 48.15% | 60.37% |
| Total Other Non-Cash Items | -87.65% | -85.53% | -85.30% | 383.88% | 351.56% |
| Change in Net Operating Assets | 102.96% | 121.32% | 95.22% | -955.79% | -411.90% |
| Cash from Operations | 0.23% | -13.42% | -8.96% | -13.04% | -16.10% |
| Capital Expenditure | 17.58% | -104.65% | -14.28% | -20.65% | 5.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -54.69% | -33.77% | -31.12% | 0.85% | 21.83% |
| Cash from Investing | -114.43% | -99.62% | -77.39% | -44.84% | 20.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -62.89% | -48.78% | -58.99% | -23.75% | -25.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -205,300.00% | -28.32% | 94.96% | 78.80% | 99.28% |
| Cash from Financing | -6,736.81% | -12,395.11% | -6,274.80% | -20.77% | -23.42% |
| Foreign Exchange rate Adjustments | 284.15% | -1.15% | 484.33% | -245.13% | -440.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -396.16% | -342.63% | -337.01% | -54.43% | -15.01% |